Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Shanghai Junshi Biosciences Co., Ltd. Class H ( (HK:1877) ) is now available.
Shanghai Junshi Biosciences Co., Ltd. has announced the closure of its H shares register from June 13 to June 20, 2025, to determine shareholder entitlements for the 2024 annual general meeting. This move is significant for stakeholders as it sets the timeline for share transfers and voting eligibility, impacting shareholder participation in the company’s governance.
The most recent analyst rating on (HK:1877) stock is a Hold with a HK$12.00 price target. To see the full list of analyst forecasts on Shanghai Junshi Biosciences Co., Ltd. Class H stock, see the HK:1877 Stock Forecast page.
More about Shanghai Junshi Biosciences Co., Ltd. Class H
Shanghai Junshi Biosciences Co., Ltd. is a joint stock company incorporated in China, operating in the biosciences industry. The company is involved in the development and commercialization of innovative therapies, with a focus on addressing unmet medical needs.
Average Trading Volume: 2,963,762
Technical Sentiment Signal: Buy
Current Market Cap: HK$29.72B
Learn more about 1877 stock on TipRanks’ Stock Analysis page.